Maykin Ho stock trades
Director at Agios Pharmaceuticals and BioMarin Pharmaceuticals
No open-market buys or sales reported in the last 12 months. Their newest Form 4, for Jun 18: stock unit conversion (2,816 AGIO shares).
The 2 companies Maykin Ho files at
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 0 | ||
| 0 |
Maykin Ho's trades, as filed
None on the open market in the last 12 months.
2 other filings on record (stock award and stock unit conversion). Pro members see every filing and the shares Maykin Ho holds.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at their companies
- Brian Goff
- Cecilia Jones
- Sarah Gheuens
- Tsveta Milanova
- James William Burns
- Krishnan Viswanadhan
- Theodore James Washburn Jr.
- David Scadden
- Catherine Owen Adams
- Cynthia Smith
- Jacqualyn A. Fouse
- Jay T. Backstrom
- Jeffrey D. Capello
- Kaye I. Foster-Cheek
- Rahul D. Ballal
- Alexander Hardy
- Brian Mueller
- George Eric Davis
- Gregory R. Friberg
- Charles Greg Guyer
- Cristin Hubbard
- Rashmi Virendra Ramchandani
- Elizabeth M. Anderson
- Ian T. Clark
- Robert J. Hombach
- Athena Countouriotis
- Barbara W. Bodem
- Mark J. Enyedy
- Robert M. Plenge
- Timothy P. Walbert
- Willard H. Dere